REMAP-CAP

Interventional COVID-19 critical care study

Lead Investigator (UK): Anthony Gordon

Participating centres: GGH, UHW, WMH, YGC

Futher details: visit ICNARC website or contact: ukremap-cap@icnarc.org

RECOVERY

Interventional COVID-19 critical care and respiratory study

Chief Investigators: Peter Horby; Martin Landray

Participating centres: GUH, WMH, YG, YGC

Further details: Recovery website

GENOMICC

Observational study: genetic predisposition to critical illness with COVID-19

Chief Investigator: Kenneth Baillie

Participating centres: GUH, SBUHB, WMH, YGC

Further details: GENOMICC website or contact: genomicc@roslin.ed.ac.uk

ISARIC

Observational study: clincal characterisation of COVID-19

Chief Investigator: Calum Semple

Participating centres: GGH, WMH, YG, YGC

Further details: ISARIC website

ADAPT Sepsis

Procalcitonin-guided antibiotic therapy

Chief Investigator: Paul Dark

For further details please visit the Warwick University CTU website or contact: adaptsepsistrial@warwick.ac.uk.

UK-ROx

Oxygen targets in the critically ill

Chief Investigators: Daniel Martin and Paul Mouncey (ICNARC)

For further details please visit the ICNARC Rox-2 webpage

MOSAICC study

Use of sodium bicarbonate in acute kidney Injury in critical care

Chief investigators: Lui Forni and Nick Selby

For further details please view here, complete site feasibility form and contact: MOSAICC@icnarc.org.

STRESS-L study

Use of a new Ultra-Short Acting Beta Blocker Landiolol in septic shock

Chief Investigator: Tony Whitehouse

For further details please view STRESS-L website or contact: STRESS-L@warwick.ac.uk

MARCH study

Mucoactives in Acute Respiratory Failure: Carbocisteine and Hypertonic Saline

Chief Investigator: Dr Brownen Connolly

Please review site feasibility questionnaire for more information and email to MARCH@nictu.hscni.net.